The discussions reference key findings from the publication, such as the 23% severe illness rate and 6% mortality, with posts using technical terms like 'risk factors' and 'clinical features,' showing a focus on the study’s significance. The tone varies from analytical to supportive, reflecting a collective recognition of the article’s impact on pandemic understanding and policy consideration.
AgreementModerate agreement
Most discussions acknowledge and support the importance of the article’s findings on COVID-19 characteristics and risk factors.
InterestModerate interest
The posts show moderate interest, referencing detailed epidemiological data and the significance of study results.
EngagementModerate engagement
There is active engagement through sharing summaries, personal opinions, and contextual reflections, indicating deep involvement.
ImpactModerate impact
The discussions highlight the importance of the article in understanding COVID-19 severity and mortality, emphasizing its relevance for public health.
Abstract in brief
This systematic review and meta-analysis examined 212 studies from 11 countries involving over 280,000 COVID-19 patients to identify common clinical features, risk factors, and outcomes, highlighting that approximately 23% develop severe illness and around 6% die from the disease.
The study found that older age, male gender, diabetes, hypertension, immunosuppression, and malignancies are strongly linked to increased severity and mortality, with underlying health conditions significantly impacting patient outcomes.
Common symptoms associated with severe COVID-19 include gastrointestinal issues such as nausea and abdominal pain, as well as respiratory symptoms like shortness of breath; pneumonia and organ failure are key factors associated with higher death risk.]
@Judit_Betulia @Doemaar1950 @the_stinging Hoi Judit,
1. Pathogenese van het coronavirus:
https://t.co/f0exhcyFc7
2. Effectiviteit én veiligheid van coronavaccins:
https://t.co/MZgNUWrhtR
3. Epidemiologie van het coronavirus:
https://t.co/H4u8A2TKQ5
4. Exit strategy uit de coronapandemie:
https://t.co/LWRWcWJLeI
Jun 1, 2022 · 5 likes · 1 share · 869 followersView post →
CE
@COVID_Evidence
@COVID_Evidence · X
PubMed: Epidemiology of COVID-19: A Systematic Review and Meta-analysis of Clinical Characteristics, Risk factors and Outcomes: CONCLUSION: COVID-19 is associated with a severe disease course in about 23% and mortality in… https://t.co/wzn14C2p6K #covid19 #SARSCOV2 #coronavirus
Aug 16, 2020 · 3 likes · 3 shares · 2,115 followersView post →
E
Ephemeral
@Ephemerallama · X
@EthicalSkeptic @rydoso Read this today: https://t.co/FupinPleS2 it's old, from early 2020 covid data, but interesting how risk for severe covid disease & death is especially high for those with kidney injury & neutropenia! Spike-athon? https://t.co/kWixEtz353
@MariaJonsson1 Sen här från meta-analys på vuxna 7.5% rinorré. Beror mkt på studiepopulation, & sannolikt mkt på svårighetsgrad. Svårare fall t.ex. oftare äldre & underliggande sjd., med annan patofysiologi än milda fall -> kommer se (& fokusera på) annan symptombild
https://t.co/ubNu5E9kfB
Jan 10, 2021 · 1 like · 3,125 followersView post →
VP
vieil_garde_PH
@vieil_garde_ph · X
https://t.co/T8JLAuptIM
M le Pr @raoult_didier a eu raison gardée, en mars 20, en l'absence de toute connaissance scientifique, de consulter, tester et traiter toute forme clinique de COVID-19
Qui, il y a 19 mois, aurait prédit l'évolution de la COVID-19 ?
un(e) con(ne)
Crlt
Aug 25, 2021 · 1 like · 1,639 followersView post →
DE
Dr Ellie
@Dr_Ellie · X
RT @COVID_Evidence: PubMed: Epidemiology of COVID-19: A Systematic Review and Meta-analysis of Clinical Characteristics, Risk factors and…
Aug 17, 2020 · 3 shares · 37,369 followersView post →
This video highlights nine key warning signs indicating severe COVID-19 and increased risk of death, emphasizing the importance of early recognition and medical attention to improve outcomes.
This video discusses whether COVID-19 is a natural pandemic or a planned event, exploring scientific references and studies on disease characteristics, risk factors, and outcomes, emphasizing the importance of…
@MaxxMustermann2 @welt Nürnberg 2.0? Drunter machst du es nicht?
https://t.co/oXUo2csE6w
Na dann mach mal.. Dass man bei Dingen, die man nicht greifen kann, auch mal falsch handelt ist halt so. Faktisch sind die meisten Maßnahmen aber Nötig gewesen, siehe USA!
@Judit_Betulia @Doemaar1950 @the_stinging Hoi Judit,
1. Pathogenese van het coronavirus:
https://t.co/f0exhcyFc7
2. Effectiviteit én veiligheid van coronavaccins:
https://t.co/MZgNUWrhtR
3. Epidemiologie van het coronavirus:
https://t.co/H4u8A2TKQ5
4. Exit strategy uit de coronapandemie:
https://t.co/LWRWcWJLeI
Jun 1, 2022 · 5 likes · 1 share · 869 followersView post →
E
Ephemeral
@Ephemerallama · X
@EthicalSkeptic @rydoso Read this today: https://t.co/FupinPleS2 it's old, from early 2020 covid data, but interesting how risk for severe covid disease & death is especially high for those with kidney injury & neutropenia! Spike-athon? https://t.co/kWixEtz353
@lupsi_pupsi @MtloxN @MrsMertes https://t.co/oXUo2cs6gY
na ich denke eine Studienserie über 280.000 Untersuchte Fälle sagt mehr aus, als ein Inaktiver Mediziner ;)
https://t.co/T8JLAuptIM
M le Pr @raoult_didier a eu raison gardée, en mars 20, en l'absence de toute connaissance scientifique, de consulter, tester et traiter toute forme clinique de COVID-19
Qui, il y a 19 mois, aurait prédit l'évolution de la COVID-19 ?
un(e) con(ne)
Crlt
Aug 25, 2021 · 1 like · 1,639 followersView post →
VP
vieil_garde_PH
@vieil_garde_ph · X
Bjr
caractéristiques cliniques ; mortalité ; facteurs de risque ; sévérité
13 août 2021
https://t.co/9FUC9pabya
Comment dire ? Non ! nous n'allons pas toutes et tous mourir de la COVID-19
âge (moyen mondial) 46,7 ans
homme 51,8%
ATCD maladies graves 22,9%
létalité 5,6%
1/5
@MariaJonsson1 Sen här från meta-analys på vuxna 7.5% rinorré. Beror mkt på studiepopulation, & sannolikt mkt på svårighetsgrad. Svårare fall t.ex. oftare äldre & underliggande sjd., med annan patofysiologi än milda fall -> kommer se (& fokusera på) annan symptombild
https://t.co/ubNu5E9kfB
Jan 10, 2021 · 1 like · 3,125 followersView post →
RT @COVID_Evidence: PubMed: Epidemiology of COVID-19: A Systematic Review and Meta-analysis of Clinical Characteristics, Risk factors and…
Aug 17, 2020 · 3 shares · 652 followersView post →
DE
Dr Ellie
@Dr_Ellie · X
RT @COVID_Evidence: PubMed: Epidemiology of COVID-19: A Systematic Review and Meta-analysis of Clinical Characteristics, Risk factors and…
Aug 17, 2020 · 3 shares · 37,369 followersView post →
CE
@COVID_Evidence
@COVID_Evidence · X
RT @COVID_Evidence: PubMed: Epidemiology of COVID-19: A Systematic Review and Meta-analysis of Clinical Characteristics, Risk factors and…
Aug 17, 2020 · 3 shares · 2,115 followersView post →
CE
@COVID_Evidence
@COVID_Evidence · X
PubMed: Epidemiology of COVID-19: A Systematic Review and Meta-analysis of Clinical Characteristics, Risk factors and Outcomes: CONCLUSION: COVID-19 is associated with a severe disease course in about 23% and mortality in… https://t.co/wzn14C2p6K #covid19 #SARSCOV2 #coronavirus
Aug 16, 2020 · 3 likes · 3 shares · 2,115 followersView post →
B
Clinical Outcome Assessments in Encephalitis: A Systematic Review ...
Blogs
From the Department of Neurology (J.B., Y.S.C., J.M.V., M.R.M., M.J.T.) ... doi:10.1002/mds.26424. 11. McKhann GM, Knopman DS, Chertkow H, et al. The ...